Imaging Firm Analogic Goes Private In Altaris Merger
Executive Summary
Altaris has agreed to pay about $1.1bn for imaging-technology developer Analogic in a deal that will move Analogic to private ownership.
You may also be interested in...
Warning Letters And Close-Outs – September 2023
It was a quiet month for warning letters at the FDA last month, with the agency issuing no new warning letters and closing out only one.
Proposed Rule Would Apply FDA’s Diagnostic Rules To LDTs
A proposed rule from the US Food and Drug Administration would allow the agency to take on regulation of lab-developed tests by phasing out the previous approach of enforcement discretion
OMB Clears Proposed Rule On Lab-Developed Tests
The US FDA appears poised to release long-promised regulations on lab-developed tests. However, some industry observers still have doubts as to whether the agency is truly prepared.